TOLEDO, OH--(Marketwire - April 21, 2008) - Gene Express, Inc. today announced that it has signed an agreement with the Division of Patents & Licensing Research Office at the University of South Florida (USF) to license some of their gene expression technology necessary to develop prognostic tests for cisplatin and irinotecan chemoresistance.
